Inactivation of the PI3K p110δ breaks regulatory T cell-mediated immune tolerance to cancer View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2014-06-11

AUTHORS

Khaled Ali, Dalya R Soond, Roberto Pineiro, Thorsten Hagemann, Wayne Pearce, Ee Lyn Lim, Hicham Bouabe, Cheryl L Scudamore, Timothy Hancox, Heather Maecker, Lori Friedman, Martin Turner, Klaus Okkenhaug, Bart Vanhaesebroeck

ABSTRACT

Inhibitors against the p110δ isoform of phosphoinositide-3-OH kinase (PI(3)K) have shown remarkable therapeutic efficacy in some human leukaemias. As p110δ is primarily expressed in leukocytes, drugs against p110δ have not been considered for the treatment of solid tumours. Here we report that p110δ inactivation in mice protects against a broad range of cancers, including non-haematological solid tumours. We demonstrate that p110δ inactivation in regulatory T cells unleashes CD8(+) cytotoxic T cells and induces tumour regression. Thus, p110δ inhibitors can break tumour-induced immune tolerance and should be considered for wider use in oncology. More... »

PAGES

407-411

References to SciGraph publications

  • 2014-01-31. PI3K and cancer: lessons, challenges and opportunities in NATURE REVIEWS DRUG DISCOVERY
  • 2012-09-21. Paths to stemness: building the ultimate antitumour T cell in NATURE REVIEWS CANCER
  • 2012-03-22. Coordinated regulation of myeloid cells by tumours in NATURE REVIEWS IMMUNOLOGY
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/nature13444

    DOI

    http://dx.doi.org/10.1038/nature13444

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1027340229

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/24919154


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Immunology", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Enzyme Activation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Enzyme Inhibitors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Immune Tolerance", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Mice", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Phosphatidylinositol 3-Kinases", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "T-Lymphocytes, Regulatory", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "UCL Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street London WC1E 6DD, UK.", 
              "id": "http://www.grid.ac/institutes/grid.83440.3b", 
              "name": [
                "UCL Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street London WC1E 6DD, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ali", 
            "givenName": "Khaled", 
            "id": "sg:person.0623103400.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623103400.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.", 
              "id": "http://www.grid.ac/institutes/grid.418195.0", 
              "name": [
                "Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Soond", 
            "givenName": "Dalya R", 
            "id": "sg:person.0666142625.66", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666142625.66"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "UCL Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street London WC1E 6DD, UK.", 
              "id": "http://www.grid.ac/institutes/grid.83440.3b", 
              "name": [
                "UCL Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street London WC1E 6DD, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pineiro", 
            "givenName": "Roberto", 
            "id": "sg:person.01041114732.72", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041114732.72"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.", 
              "id": "http://www.grid.ac/institutes/grid.4868.2", 
              "name": [
                "Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hagemann", 
            "givenName": "Thorsten", 
            "id": "sg:person.013224364717.81", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013224364717.81"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "UCL Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street London WC1E 6DD, UK.", 
              "id": "http://www.grid.ac/institutes/grid.83440.3b", 
              "name": [
                "UCL Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street London WC1E 6DD, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pearce", 
            "givenName": "Wayne", 
            "id": "sg:person.0642215357.33", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642215357.33"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.", 
              "id": "http://www.grid.ac/institutes/grid.418195.0", 
              "name": [
                "Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Lim", 
            "givenName": "Ee Lyn", 
            "id": "sg:person.01065140032.25", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065140032.25"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.", 
              "id": "http://www.grid.ac/institutes/grid.418195.0", 
              "name": [
                "Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bouabe", 
            "givenName": "Hicham", 
            "id": "sg:person.0712310373.12", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712310373.12"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Pathology and Infectious Diseases, Royal Veterinary College, Hawkshead Lane, Hatfield, Hertfordshire AL9 7TA, UK.", 
              "id": "http://www.grid.ac/institutes/grid.20931.39", 
              "name": [
                "Department of Pathology and Infectious Diseases, Royal Veterinary College, Hawkshead Lane, Hatfield, Hertfordshire AL9 7TA, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Scudamore", 
            "givenName": "Cheryl L", 
            "id": "sg:person.01105327076.00", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105327076.00"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Piramed Pharma, 957 Buckingham Avenue, Slough, Berkshire, SL1 4NL, UK.", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Piramed Pharma, 957 Buckingham Avenue, Slough, Berkshire, SL1 4NL, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Hancox", 
            "givenName": "Timothy", 
            "id": "sg:person.01247501632.20", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247501632.20"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Signaling and Translational Oncology, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080-4990, USA.", 
              "id": "http://www.grid.ac/institutes/grid.418158.1", 
              "name": [
                "Cancer Signaling and Translational Oncology, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080-4990, USA."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Maecker", 
            "givenName": "Heather", 
            "id": "sg:person.01367127301.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367127301.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Cancer Signaling and Translational Oncology, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080-4990, USA.", 
              "id": "http://www.grid.ac/institutes/grid.418158.1", 
              "name": [
                "Cancer Signaling and Translational Oncology, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080-4990, USA."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Friedman", 
            "givenName": "Lori", 
            "id": "sg:person.01176112205.42", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176112205.42"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.", 
              "id": "http://www.grid.ac/institutes/grid.418195.0", 
              "name": [
                "Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Turner", 
            "givenName": "Martin", 
            "id": "sg:person.01004526450.65", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004526450.65"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.", 
              "id": "http://www.grid.ac/institutes/grid.418195.0", 
              "name": [
                "Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Okkenhaug", 
            "givenName": "Klaus", 
            "id": "sg:person.01356616513.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356616513.06"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "UCL Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street London WC1E 6DD, UK.", 
              "id": "http://www.grid.ac/institutes/grid.83440.3b", 
              "name": [
                "UCL Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street London WC1E 6DD, UK."
              ], 
              "type": "Organization"
            }, 
            "familyName": "Vanhaesebroeck", 
            "givenName": "Bart", 
            "id": "sg:person.01077036717.10", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077036717.10"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nrd4204", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035315734", 
              "https://doi.org/10.1038/nrd4204"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrc3322", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012699855", 
              "https://doi.org/10.1038/nrc3322"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nri3175", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017497994", 
              "https://doi.org/10.1038/nri3175"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2014-06-11", 
        "datePublishedReg": "2014-06-11", 
        "description": "Inhibitors against the p110\u03b4 isoform of phosphoinositide-3-OH kinase (PI(3)K) have shown remarkable therapeutic efficacy in some human leukaemias. As p110\u03b4 is primarily expressed in leukocytes, drugs against p110\u03b4 have not been considered for the treatment of solid tumours. Here we report that p110\u03b4 inactivation in mice protects against a broad range of cancers, including non-haematological solid tumours. We demonstrate that p110\u03b4 inactivation in regulatory T cells unleashes CD8(+) cytotoxic T cells and induces tumour regression. Thus, p110\u03b4 inhibitors can break tumour-induced immune tolerance and should be considered for wider use in oncology.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/nature13444", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.5136037", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2768236", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.3957385", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2780918", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.2777680", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.5498354", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.5139453", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.5141152", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.3635849", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1018957", 
            "issn": [
              "0028-0836", 
              "1476-4687"
            ], 
            "name": "Nature", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "7505", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "510"
          }
        ], 
        "keywords": [
          "immune tolerance", 
          "solid tumors", 
          "tumor-induced immune tolerance", 
          "cell-mediated immune tolerance", 
          "p110\u03b4 inactivation", 
          "remarkable therapeutic efficacy", 
          "PI3K p110\u03b4", 
          "therapeutic efficacy", 
          "p110\u03b4 inhibitor", 
          "phosphoinositide-3-OH kinase", 
          "p110\u03b4 isoform", 
          "human leukemia", 
          "tumors", 
          "p110\u03b4", 
          "cancer", 
          "inhibitors", 
          "cells", 
          "leukemia", 
          "leukocytes", 
          "inactivation", 
          "mice", 
          "oncology", 
          "drugs", 
          "efficacy", 
          "treatment", 
          "tolerance", 
          "wide use", 
          "regression", 
          "isoforms", 
          "kinase", 
          "broad range", 
          "use", 
          "range", 
          "non-haematological solid tumours", 
          "K p110\u03b4"
        ], 
        "name": "Inactivation of the PI3K p110\u03b4 breaks regulatory T cell-mediated immune tolerance to cancer", 
        "pagination": "407-411", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1027340229"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/nature13444"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "24919154"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/nature13444", 
          "https://app.dimensions.ai/details/publication/pub.1027340229"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:31", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_620.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/nature13444"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/nature13444'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/nature13444'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/nature13444'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/nature13444'


     

    This table displays all metadata directly associated to this object as RDF triples.

    273 TRIPLES      22 PREDICATES      74 URIs      62 LITERALS      16 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/nature13444 schema:about N1b92de8a5f8347b59cd8dd6a1eb0c914
    2 N363143e764254391bcc044e7402a7583
    3 N37890323690d49afa6ea532367111c95
    4 N38f174d9b91243bf902e432b6e73f953
    5 N53581cc312c24cad93271c40c1811b51
    6 N5cf1ad8c02364dd09cfce7f09193beb1
    7 N6561af27d39a4514aa6c3a8dee43115b
    8 N6f275559668f446e86ce9d5e5f1cb36e
    9 Nce4cc64afb1c4809a174e7972c6a059c
    10 anzsrc-for:11
    11 anzsrc-for:1107
    12 anzsrc-for:1112
    13 schema:author Na0958aa0eaec47428b05ce58329c814d
    14 schema:citation sg:pub.10.1038/nrc3322
    15 sg:pub.10.1038/nrd4204
    16 sg:pub.10.1038/nri3175
    17 schema:datePublished 2014-06-11
    18 schema:datePublishedReg 2014-06-11
    19 schema:description Inhibitors against the p110δ isoform of phosphoinositide-3-OH kinase (PI(3)K) have shown remarkable therapeutic efficacy in some human leukaemias. As p110δ is primarily expressed in leukocytes, drugs against p110δ have not been considered for the treatment of solid tumours. Here we report that p110δ inactivation in mice protects against a broad range of cancers, including non-haematological solid tumours. We demonstrate that p110δ inactivation in regulatory T cells unleashes CD8(+) cytotoxic T cells and induces tumour regression. Thus, p110δ inhibitors can break tumour-induced immune tolerance and should be considered for wider use in oncology.
    20 schema:genre article
    21 schema:inLanguage en
    22 schema:isAccessibleForFree true
    23 schema:isPartOf N4133bed013a646909c6ff72c70a105e9
    24 N881189ee3b20410596fe5fc031a3788e
    25 sg:journal.1018957
    26 schema:keywords K p110δ
    27 PI3K p110δ
    28 broad range
    29 cancer
    30 cell-mediated immune tolerance
    31 cells
    32 drugs
    33 efficacy
    34 human leukemia
    35 immune tolerance
    36 inactivation
    37 inhibitors
    38 isoforms
    39 kinase
    40 leukemia
    41 leukocytes
    42 mice
    43 non-haematological solid tumours
    44 oncology
    45 p110δ
    46 p110δ inactivation
    47 p110δ inhibitor
    48 p110δ isoform
    49 phosphoinositide-3-OH kinase
    50 range
    51 regression
    52 remarkable therapeutic efficacy
    53 solid tumors
    54 therapeutic efficacy
    55 tolerance
    56 treatment
    57 tumor-induced immune tolerance
    58 tumors
    59 use
    60 wide use
    61 schema:name Inactivation of the PI3K p110δ breaks regulatory T cell-mediated immune tolerance to cancer
    62 schema:pagination 407-411
    63 schema:productId N06b06bcfcf574e40a373bc18fd258f5e
    64 N45970b1a2fd24598815764f51f0bf3d2
    65 N5080c0bef16247349220ea2e58953330
    66 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027340229
    67 https://doi.org/10.1038/nature13444
    68 schema:sdDatePublished 2021-12-01T19:31
    69 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    70 schema:sdPublisher N913fe4a8e4004f8797f353178f0c03f3
    71 schema:url https://doi.org/10.1038/nature13444
    72 sgo:license sg:explorer/license/
    73 sgo:sdDataset articles
    74 rdf:type schema:ScholarlyArticle
    75 N06b06bcfcf574e40a373bc18fd258f5e schema:name dimensions_id
    76 schema:value pub.1027340229
    77 rdf:type schema:PropertyValue
    78 N191f971e1e284d84af865e62102e5086 rdf:first sg:person.01105327076.00
    79 rdf:rest Ne2e7cd5efaa14a9083a7ff38d24bc56e
    80 N1b92de8a5f8347b59cd8dd6a1eb0c914 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    81 schema:name Mice
    82 rdf:type schema:DefinedTerm
    83 N1fe25cce8c794762aa1ed105f3e77c27 rdf:first sg:person.01077036717.10
    84 rdf:rest rdf:nil
    85 N363143e764254391bcc044e7402a7583 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    86 schema:name Animals
    87 rdf:type schema:DefinedTerm
    88 N37890323690d49afa6ea532367111c95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    89 schema:name T-Lymphocytes, Regulatory
    90 rdf:type schema:DefinedTerm
    91 N38f174d9b91243bf902e432b6e73f953 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    92 schema:name Enzyme Activation
    93 rdf:type schema:DefinedTerm
    94 N4133bed013a646909c6ff72c70a105e9 schema:volumeNumber 510
    95 rdf:type schema:PublicationVolume
    96 N45970b1a2fd24598815764f51f0bf3d2 schema:name doi
    97 schema:value 10.1038/nature13444
    98 rdf:type schema:PropertyValue
    99 N5080c0bef16247349220ea2e58953330 schema:name pubmed_id
    100 schema:value 24919154
    101 rdf:type schema:PropertyValue
    102 N53581cc312c24cad93271c40c1811b51 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    103 schema:name Antineoplastic Agents
    104 rdf:type schema:DefinedTerm
    105 N5beae4e8aa8d47f3b3a9d0bd5d383d95 rdf:first sg:person.0642215357.33
    106 rdf:rest Ndc3a2fa1f9b04eeb8178c7f6b06da779
    107 N5cf1ad8c02364dd09cfce7f09193beb1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    108 schema:name Neoplasms
    109 rdf:type schema:DefinedTerm
    110 N6561af27d39a4514aa6c3a8dee43115b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    111 schema:name Immune Tolerance
    112 rdf:type schema:DefinedTerm
    113 N6f275559668f446e86ce9d5e5f1cb36e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    114 schema:name Enzyme Inhibitors
    115 rdf:type schema:DefinedTerm
    116 N881189ee3b20410596fe5fc031a3788e schema:issueNumber 7505
    117 rdf:type schema:PublicationIssue
    118 N8b54e8463826424e9f97fa982d12959b rdf:first sg:person.01004526450.65
    119 rdf:rest Ndcf7c60cba28442e8b5c4d53ad1331e0
    120 N913fe4a8e4004f8797f353178f0c03f3 schema:name Springer Nature - SN SciGraph project
    121 rdf:type schema:Organization
    122 Na0958aa0eaec47428b05ce58329c814d rdf:first sg:person.0623103400.33
    123 rdf:rest Nb7c04f945fbf49819d4707edebb78a30
    124 Nb7c04f945fbf49819d4707edebb78a30 rdf:first sg:person.0666142625.66
    125 rdf:rest Ne4cd069a0bf74b38a14ed61bd44756fb
    126 Ncccb3ebdb9fa4cd8ad3d50384f25c943 rdf:first sg:person.01176112205.42
    127 rdf:rest N8b54e8463826424e9f97fa982d12959b
    128 Nce4cc64afb1c4809a174e7972c6a059c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Phosphatidylinositol 3-Kinases
    130 rdf:type schema:DefinedTerm
    131 Nd286060bf9d84ce5bd7c1348c515dc49 rdf:first sg:person.0712310373.12
    132 rdf:rest N191f971e1e284d84af865e62102e5086
    133 Ndc3a2fa1f9b04eeb8178c7f6b06da779 rdf:first sg:person.01065140032.25
    134 rdf:rest Nd286060bf9d84ce5bd7c1348c515dc49
    135 Ndcf7c60cba28442e8b5c4d53ad1331e0 rdf:first sg:person.01356616513.06
    136 rdf:rest N1fe25cce8c794762aa1ed105f3e77c27
    137 Ne2e7cd5efaa14a9083a7ff38d24bc56e rdf:first sg:person.01247501632.20
    138 rdf:rest Ne60f759068094929bf9d90dd76de0a2c
    139 Ne4cd069a0bf74b38a14ed61bd44756fb rdf:first sg:person.01041114732.72
    140 rdf:rest Nf793db55c6eb4690a3ad23774b2ef569
    141 Ne60f759068094929bf9d90dd76de0a2c rdf:first sg:person.01367127301.38
    142 rdf:rest Ncccb3ebdb9fa4cd8ad3d50384f25c943
    143 Nf793db55c6eb4690a3ad23774b2ef569 rdf:first sg:person.013224364717.81
    144 rdf:rest N5beae4e8aa8d47f3b3a9d0bd5d383d95
    145 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    146 schema:name Medical and Health Sciences
    147 rdf:type schema:DefinedTerm
    148 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
    149 schema:name Immunology
    150 rdf:type schema:DefinedTerm
    151 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    152 schema:name Oncology and Carcinogenesis
    153 rdf:type schema:DefinedTerm
    154 sg:grant.2768236 http://pending.schema.org/fundedItem sg:pub.10.1038/nature13444
    155 rdf:type schema:MonetaryGrant
    156 sg:grant.2777680 http://pending.schema.org/fundedItem sg:pub.10.1038/nature13444
    157 rdf:type schema:MonetaryGrant
    158 sg:grant.2780918 http://pending.schema.org/fundedItem sg:pub.10.1038/nature13444
    159 rdf:type schema:MonetaryGrant
    160 sg:grant.3635849 http://pending.schema.org/fundedItem sg:pub.10.1038/nature13444
    161 rdf:type schema:MonetaryGrant
    162 sg:grant.3957385 http://pending.schema.org/fundedItem sg:pub.10.1038/nature13444
    163 rdf:type schema:MonetaryGrant
    164 sg:grant.5136037 http://pending.schema.org/fundedItem sg:pub.10.1038/nature13444
    165 rdf:type schema:MonetaryGrant
    166 sg:grant.5139453 http://pending.schema.org/fundedItem sg:pub.10.1038/nature13444
    167 rdf:type schema:MonetaryGrant
    168 sg:grant.5141152 http://pending.schema.org/fundedItem sg:pub.10.1038/nature13444
    169 rdf:type schema:MonetaryGrant
    170 sg:grant.5498354 http://pending.schema.org/fundedItem sg:pub.10.1038/nature13444
    171 rdf:type schema:MonetaryGrant
    172 sg:journal.1018957 schema:issn 0028-0836
    173 1476-4687
    174 schema:name Nature
    175 schema:publisher Springer Nature
    176 rdf:type schema:Periodical
    177 sg:person.01004526450.65 schema:affiliation grid-institutes:grid.418195.0
    178 schema:familyName Turner
    179 schema:givenName Martin
    180 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01004526450.65
    181 rdf:type schema:Person
    182 sg:person.01041114732.72 schema:affiliation grid-institutes:grid.83440.3b
    183 schema:familyName Pineiro
    184 schema:givenName Roberto
    185 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01041114732.72
    186 rdf:type schema:Person
    187 sg:person.01065140032.25 schema:affiliation grid-institutes:grid.418195.0
    188 schema:familyName Lim
    189 schema:givenName Ee Lyn
    190 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01065140032.25
    191 rdf:type schema:Person
    192 sg:person.01077036717.10 schema:affiliation grid-institutes:grid.83440.3b
    193 schema:familyName Vanhaesebroeck
    194 schema:givenName Bart
    195 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077036717.10
    196 rdf:type schema:Person
    197 sg:person.01105327076.00 schema:affiliation grid-institutes:grid.20931.39
    198 schema:familyName Scudamore
    199 schema:givenName Cheryl L
    200 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105327076.00
    201 rdf:type schema:Person
    202 sg:person.01176112205.42 schema:affiliation grid-institutes:grid.418158.1
    203 schema:familyName Friedman
    204 schema:givenName Lori
    205 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176112205.42
    206 rdf:type schema:Person
    207 sg:person.01247501632.20 schema:affiliation grid-institutes:None
    208 schema:familyName Hancox
    209 schema:givenName Timothy
    210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247501632.20
    211 rdf:type schema:Person
    212 sg:person.013224364717.81 schema:affiliation grid-institutes:grid.4868.2
    213 schema:familyName Hagemann
    214 schema:givenName Thorsten
    215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013224364717.81
    216 rdf:type schema:Person
    217 sg:person.01356616513.06 schema:affiliation grid-institutes:grid.418195.0
    218 schema:familyName Okkenhaug
    219 schema:givenName Klaus
    220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356616513.06
    221 rdf:type schema:Person
    222 sg:person.01367127301.38 schema:affiliation grid-institutes:grid.418158.1
    223 schema:familyName Maecker
    224 schema:givenName Heather
    225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01367127301.38
    226 rdf:type schema:Person
    227 sg:person.0623103400.33 schema:affiliation grid-institutes:grid.83440.3b
    228 schema:familyName Ali
    229 schema:givenName Khaled
    230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623103400.33
    231 rdf:type schema:Person
    232 sg:person.0642215357.33 schema:affiliation grid-institutes:grid.83440.3b
    233 schema:familyName Pearce
    234 schema:givenName Wayne
    235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642215357.33
    236 rdf:type schema:Person
    237 sg:person.0666142625.66 schema:affiliation grid-institutes:grid.418195.0
    238 schema:familyName Soond
    239 schema:givenName Dalya R
    240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0666142625.66
    241 rdf:type schema:Person
    242 sg:person.0712310373.12 schema:affiliation grid-institutes:grid.418195.0
    243 schema:familyName Bouabe
    244 schema:givenName Hicham
    245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0712310373.12
    246 rdf:type schema:Person
    247 sg:pub.10.1038/nrc3322 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012699855
    248 https://doi.org/10.1038/nrc3322
    249 rdf:type schema:CreativeWork
    250 sg:pub.10.1038/nrd4204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035315734
    251 https://doi.org/10.1038/nrd4204
    252 rdf:type schema:CreativeWork
    253 sg:pub.10.1038/nri3175 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017497994
    254 https://doi.org/10.1038/nri3175
    255 rdf:type schema:CreativeWork
    256 grid-institutes:None schema:alternateName Piramed Pharma, 957 Buckingham Avenue, Slough, Berkshire, SL1 4NL, UK.
    257 schema:name Piramed Pharma, 957 Buckingham Avenue, Slough, Berkshire, SL1 4NL, UK.
    258 rdf:type schema:Organization
    259 grid-institutes:grid.20931.39 schema:alternateName Department of Pathology and Infectious Diseases, Royal Veterinary College, Hawkshead Lane, Hatfield, Hertfordshire AL9 7TA, UK.
    260 schema:name Department of Pathology and Infectious Diseases, Royal Veterinary College, Hawkshead Lane, Hatfield, Hertfordshire AL9 7TA, UK.
    261 rdf:type schema:Organization
    262 grid-institutes:grid.418158.1 schema:alternateName Cancer Signaling and Translational Oncology, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080-4990, USA.
    263 schema:name Cancer Signaling and Translational Oncology, Genentech Inc, 1 DNA Way, South San Francisco, CA 94080-4990, USA.
    264 rdf:type schema:Organization
    265 grid-institutes:grid.418195.0 schema:alternateName Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.
    266 schema:name Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.
    267 rdf:type schema:Organization
    268 grid-institutes:grid.4868.2 schema:alternateName Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
    269 schema:name Centre for Cancer and Inflammation, Barts Cancer Institute, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK.
    270 rdf:type schema:Organization
    271 grid-institutes:grid.83440.3b schema:alternateName UCL Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street London WC1E 6DD, UK.
    272 schema:name UCL Cancer Institute, Paul O'Gorman Building, University College London, 72 Huntley Street London WC1E 6DD, UK.
    273 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...